| 000 | 01820 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513130129.0 | ||
| 264 | 0 | _c19971030 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1997.15.10.3266 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaloney, D G | |
| 245 | 0 | 0 |
_aIDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cOct 1997 |
||
| 300 |
_a3266-74 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xanalysis |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aLymphocyte Subsets |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aGrillo-López, A J | |
| 700 | 1 | _aBodkin, D J | |
| 700 | 1 | _aWhite, C A | |
| 700 | 1 | _aLiles, T M | |
| 700 | 1 | _aRoyston, I | |
| 700 | 1 | _aVarns, C | |
| 700 | 1 | _aRosenberg, J | |
| 700 | 1 | _aLevy, R | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 15 _gno. 10 _gp. 3266-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1997.15.10.3266 _zAvailable from publisher's website |
| 999 |
_c9308617 _d9308617 |
||